CDC OK’s Novavax vaccine to add fifth shot to U.S. program, and COVID cases triple in Europe in six-week span

The U.S. Centers for Disease Control and Prevention authorized the Novavax vaccine for adults late Tuesday, clearing the final obstacle to the use of a fourth alternative and one that is based on more traditional technology than earlier shots.